{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:15:38Z","timestamp":1766067338109},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fatty liver index (FLI), a predictor of nonalcoholic fatty liver disease, has been reported to be associated with several metabolic disorders. This study aimed to evaluate the relationship between FLI and new onset of diabetes mellitus (DM). We investigated the association of FLI with new onset of DM during a 10-year period in subjects who received annual health examinations (n\u2009=\u200928,990). After exclusion of subjects with DM at baseline and those with missing data, a total of 12,290 subjects (male\/female: 7925\/4365) who received health examinations were recruited. FLI was significantly higher in males than in females. During the 10-year period, DM was developed in 533 males (6.7%) and 128 females (2.9%). Multivariable Cox proportional hazard models with a restricted cubic spline showed that the risk of new onset of DM increased with a higher FLI at baseline in both sexes after adjustment of age, fasting plasma glucose, habits of alcohol drinking and current smoking, family history of DM and diagnosis of hypertension and dyslipidemia at baseline. When the subjects were divided into subgroups according to tertiles of FLI level at baseline (T1\u2013T3) in the absence and presence of impaired fasting glucose (IFG), hazard ratios after adjustment of the confounders gradually increased from T1 to T3 and from the absence to presence of IFG in both male and female subjects. In conclusion, a high level of FLI predicts new onset of DM in a general population of both male and female individuals.<\/jats:p>","DOI":"10.1038\/s41598-021-92292-y","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:03:33Z","timestamp":1624010613000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects"],"prefix":"10.1038","volume":"11","author":[{"given":"Yukimura","family":"Higashiura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hisasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagisa","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Moniwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"92292_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino, F. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 41, 255\u2013323. https:\/\/doi.org\/10.1093\/eurheartj\/ehz486 (2020).","journal-title":"Eur. Heart J."},{"key":"92292_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova, K. et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128, 40\u201350. https:\/\/doi.org\/10.1016\/j.diabres.2017.03.024 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"92292_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJM199507133330203","volume":"333","author":"J Partanen","year":"1995","unstructured":"Partanen, J. et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 89\u201394. https:\/\/doi.org\/10.1056\/NEJM199507133330203 (1995).","journal-title":"N. Engl. J. Med."},{"key":"92292_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon, B. M. & Maddox, T. M. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes 6, 1246\u20131258. https:\/\/doi.org\/10.4239\/wjd.v6.i13.1246 (2015).","journal-title":"World J. Diabetes"},{"key":"92292_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","volume":"47","author":"A Lonardo","year":"2015","unstructured":"Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P. & Loria, P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig. Liver Dis. 47, 181\u2013190. https:\/\/doi.org\/10.1016\/j.dld.2014.09.020 (2015).","journal-title":"Dig. Liver Dis."},{"key":"92292_CR6","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang, K. C. et al. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci. Rep. 6, 27034. https:\/\/doi.org\/10.1038\/srep27034 (2016).","journal-title":"Sci. Rep."},{"key":"92292_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J. Hepatol. 69, 896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036 (2018).","journal-title":"J. Hepatol."},{"key":"92292_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology 64, 1577\u20131586. https:\/\/doi.org\/10.1002\/hep.28785 (2016).","journal-title":"Hepatology"},{"key":"92292_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/ajg.2013.349","volume":"108","author":"Y Chang","year":"2013","unstructured":"Chang, Y. et al. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am. J. Gastroenterol. 108, 1861\u20131868. https:\/\/doi.org\/10.1038\/ajg.2013.349 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"92292_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri, S. et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 31, 936\u2013944. https:\/\/doi.org\/10.1111\/jgh.13264 (2016).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"92292_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/07853890.2010.518623","volume":"43","author":"G Musso","year":"2011","unstructured":"Musso, G., Gambino, R., Cassader, M. & Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617\u2013649. https:\/\/doi.org\/10.3109\/07853890.2010.518623 (2011).","journal-title":"Ann. Med."},{"key":"92292_CR12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri, B. A. & Caldwell, S. H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37, 1202\u20131219. https:\/\/doi.org\/10.1053\/jhep.2003.50193 (2003).","journal-title":"Hepatology"},{"key":"92292_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4254\/wjh.v7.i4.638","volume":"7","author":"M Papagianni","year":"2015","unstructured":"Papagianni, M., Sofogianni, A. & Tziomalos, K. Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World J. Hepatol. 7, 638\u2013648. https:\/\/doi.org\/10.4254\/wjh.v7.i4.638 (2015).","journal-title":"World J. Hepatol."},{"key":"92292_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33. https:\/\/doi.org\/10.1186\/1471-230X-6-33 (2006).","journal-title":"BMC Gastroenterol."},{"key":"92292_CR15","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/jgh.12665","volume":"29","author":"M Otgonsuren","year":"2014","unstructured":"Otgonsuren, M. et al. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). J. Gastroenterol. Hepatol. 29, 2006\u20132013. https:\/\/doi.org\/10.1111\/jgh.12665 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"92292_CR16","doi-asserted-by":"publisher","first-page":"e0120443","DOI":"10.1371\/journal.pone.0120443","volume":"10","author":"BL Yang","year":"2015","unstructured":"Yang, B. L. et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE 10, e0120443. https:\/\/doi.org\/10.1371\/journal.pone.0120443 (2015).","journal-title":"PLoS ONE"},{"key":"92292_CR17","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Validation of the Fatty Liver Index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore) 94, e1682. https:\/\/doi.org\/10.1097\/MD.0000000000001682 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"92292_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-230X-10-56","volume":"10","author":"B Balkau","year":"2010","unstructured":"Balkau, B. et al. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 10, 56. https:\/\/doi.org\/10.1186\/1471-230X-10-56 (2010).","journal-title":"BMC Gastroenterol."},{"key":"92292_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/dme.12104","volume":"30","author":"CH Jung","year":"2013","unstructured":"Jung, C. H. et al. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. Diabet. Med. 30, 428\u2013435. https:\/\/doi.org\/10.1111\/dme.12104 (2013).","journal-title":"Diabet. Med."},{"key":"92292_CR20","doi-asserted-by":"publisher","first-page":"e4447","DOI":"10.1097\/MD.0000000000004447","volume":"95","author":"D Yadav","year":"2016","unstructured":"Yadav, D. et al. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study. Medicine (Baltimore) 95, e4447. https:\/\/doi.org\/10.1097\/MD.0000000000004447 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"92292_CR21","doi-asserted-by":"publisher","first-page":"e0124749","DOI":"10.1371\/journal.pone.0124749","volume":"10","author":"S Jager","year":"2015","unstructured":"Jager, S. et al. Association between the Fatty Liver Index and risk of type 2 diabetes in the EPIC-Potsdam Study. PLoS ONE 10, e0124749. https:\/\/doi.org\/10.1371\/journal.pone.0124749 (2015).","journal-title":"PLoS ONE"},{"key":"92292_CR22","doi-asserted-by":"publisher","first-page":"e0198327","DOI":"10.1371\/journal.pone.0198327","volume":"13","author":"J Franch-Nadal","year":"2018","unstructured":"Franch-Nadal, J. et al. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: the PREDAPS study. PLoS ONE 13, e0198327. https:\/\/doi.org\/10.1371\/journal.pone.0198327 (2018).","journal-title":"PLoS ONE"},{"key":"92292_CR23","doi-asserted-by":"publisher","first-page":"e0221524","DOI":"10.1371\/journal.pone.0221524","volume":"14","author":"M Wargny","year":"2019","unstructured":"Wargny, M. et al. Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: the IT-DIAB study. PLoS ONE 14, e0221524. https:\/\/doi.org\/10.1371\/journal.pone.0221524 (2019).","journal-title":"PLoS ONE"},{"key":"92292_CR24","doi-asserted-by":"publisher","first-page":"e026949","DOI":"10.1136\/bmjopen-2018-026949","volume":"9","author":"OO Olubamwo","year":"2019","unstructured":"Olubamwo, O. O., Virtanen, J. K., Pihlajamaki, J. & Tuomainen, T. P. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study. BMJ Open 9, e026949. https:\/\/doi.org\/10.1136\/bmjopen-2018-026949 (2019).","journal-title":"BMJ Open"},{"key":"92292_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/hepr.13065","volume":"48","author":"A Hirata","year":"2018","unstructured":"Hirata, A. et al. Fatty liver index predicts incident diabetes in a Japanese general population with and without impaired fasting glucose. Hepatol. Res. 48, 708\u2013716. https:\/\/doi.org\/10.1111\/hepr.13065 (2018).","journal-title":"Hepatol. Res."},{"key":"92292_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/DMSO.S189544","volume":"12","author":"AR Khang","year":"2019","unstructured":"Khang, A. R., Lee, H. W., Yi, D., Kang, Y. H. & Son, S. M. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010\u20132011. Diabetes Metab. Syndr. Obes. 12, 181\u2013190. https:\/\/doi.org\/10.2147\/DMSO.S189544 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"92292_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"Examination Committee of Criteria for 'Obesity Disease' in, J. & Japan Society for the Study of, O","year":"2002","unstructured":"Examination Committee of Criteria for \u201cObesity Disease\u201d in, J. & Japan Society for the Study of, O. New criteria for \u201cobesity disease\u201d in Japan. Circ. J. 66, 987\u2013992. https:\/\/doi.org\/10.1253\/circj.66.987 (2002).","journal-title":"Circ. J."},{"key":"92292_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2169\/internalmedicine.49.3006","volume":"49","author":"H Satoh","year":"2010","unstructured":"Satoh, H., Kishi, R. & Tsutsui, H. Body mass index can similarly predict the presence of multiple cardiovascular risk factors in middle-aged Japanese subjects as waist circumference. Intern. Med. 49, 977\u2013982. https:\/\/doi.org\/10.2169\/internalmedicine.49.3006 (2010).","journal-title":"Intern. Med."},{"key":"92292_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12199-010-0165-y","volume":"16","author":"K Nakamura","year":"2011","unstructured":"Nakamura, K. et al. Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women. Environ. Health Prev. Med. 16, 52\u201360. https:\/\/doi.org\/10.1007\/s12199-010-0165-y (2011).","journal-title":"Environ. Health Prev. Med."},{"key":"92292_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.5551\/jat.11528","volume":"19","author":"M Unno","year":"2012","unstructured":"Unno, M. et al. The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome\u2014the results of the Kyushu and Okinawa Population Study (KOPS). J. Atheroscler. Thromb 19, 462\u2013470. https:\/\/doi.org\/10.5551\/jat.11528 (2012).","journal-title":"J. Atheroscler. Thromb"},{"key":"92292_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","volume":"20","author":"HS Kalia","year":"2016","unstructured":"Kalia, H. S. & Gaglio, P. J. The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities. Clin. Liver Dis. 20, 215\u2013224. https:\/\/doi.org\/10.1016\/j.cld.2015.10.005 (2016).","journal-title":"Clin. Liver Dis."},{"key":"92292_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/liv.13185","volume":"36","author":"L Valenti","year":"2016","unstructured":"Valenti, L., Bugianesi, E., Pajvani, U. & Targher, G. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?. Liver Int. 36, 1563\u20131579. https:\/\/doi.org\/10.1111\/liv.13185 (2016).","journal-title":"Liver Int."},{"key":"92292_CR33","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","volume":"87","author":"A Seppala-Lindroos","year":"2002","unstructured":"Seppala-Lindroos, A. et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87, 3023\u20133028. https:\/\/doi.org\/10.1210\/jcem.87.7.8638 (2002).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"92292_CR34","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep.22845","volume":"49","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli, A. et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49, 1537\u20131544. https:\/\/doi.org\/10.1002\/hep.22845 (2009).","journal-title":"Hepatology"},{"key":"92292_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal, D. et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18, 1279\u20131285. https:\/\/doi.org\/10.1038\/nm.2851 (2012).","journal-title":"Nat. Med."},{"key":"92292_CR36","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun, T. et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018\u20136027. https:\/\/doi.org\/10.1210\/en.2008-0816 (2008).","journal-title":"Endocrinology"},{"key":"92292_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250\u2013259. https:\/\/doi.org\/10.2337\/db08-0392 (2009).","journal-title":"Diabetes"},{"key":"92292_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","volume":"12","author":"H Misu","year":"2010","unstructured":"Misu, H. et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12, 483\u2013495. https:\/\/doi.org\/10.1016\/j.cmet.2010.09.015 (2010).","journal-title":"Cell Metab."},{"key":"92292_CR39","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1253\/circj.CJ-18-0082","volume":"82","author":"M Furuhashi","year":"2018","unstructured":"Furuhashi, M. et al. Plasma xanthine oxidoreductase activity as a novel biomarker of metabolic disorders in a general population. Circ. J. 82, 1892\u20131899. https:\/\/doi.org\/10.1253\/circj.CJ-18-0082 (2018).","journal-title":"Circ. J."},{"key":"92292_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1507\/endocrj.EJ19-0053","volume":"66","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi, M. et al. Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight. Endocr. J. 66, 777\u2013786. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0053 (2019).","journal-title":"Endocr. J."},{"key":"92292_CR41","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi, M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am. J. Physiol. Endocrinol. Metab. 319, E827\u2013E834. https:\/\/doi.org\/10.1152\/ajpendo.00378.2020 (2020).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"92292_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler, E. M. et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin. Gastroenterol. Hepatol. 11, 1201\u20131204. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.031 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"92292_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000076640","volume":"47","author":"J Tanaka","year":"2004","unstructured":"Tanaka, J. et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995\u20132000. Intervirology 47, 32\u201340. https:\/\/doi.org\/10.1159\/000076640 (2004).","journal-title":"Intervirology"},{"key":"92292_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000324525","volume":"54","author":"J Tanaka","year":"2011","unstructured":"Tanaka, J. et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology 54, 185\u2013195. https:\/\/doi.org\/10.1159\/000324525 (2011).","journal-title":"Intervirology"},{"key":"92292_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13284","author":"Y Higashiura","year":"2020","unstructured":"Higashiura, Y. et al. Low urine pH predicts new onset of diabetes mellitus during a 10-year period in men: BOREAS-DM1 study. J. Diabetes Invest. https:\/\/doi.org\/10.1111\/jdi.13284 (2020).","journal-title":"J. Diabetes Invest."},{"key":"92292_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0532-z","author":"K Mori","year":"2020","unstructured":"Mori, K. et al. U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2. Hypertens. Res. https:\/\/doi.org\/10.1038\/s41440-020-0532-z (2020).","journal-title":"Hypertens. Res."},{"key":"92292_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982\u2013992. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"92292_CR48","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association 2","year":"2017","unstructured":"American Diabetes Association 2. Classification and diagnosis of diabetes. Diabetes Care 40, S11\u2013S24. https:\/\/doi.org\/10.2337\/dc17-S005 (2017).","journal-title":"Diabetes Care"},{"key":"92292_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"Schisterman, E. F., Perkins, N. J., Liu, A. & Bondell, H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 16, 73\u201381. https:\/\/doi.org\/10.1097\/01.ede.0000147512.81966.ba (2005).","journal-title":"Epidemiology"},{"key":"92292_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92292-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:17:40Z","timestamp":1670062660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92292"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92292-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"23 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12830"}}